GENE ONLINE|News &
Opinion
Blog

Aduhelm
Special Aduhelm
The FDA and Biogen Taking Heat for Aduhelm’s Approval Process
2022-12-30
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
Ranking & Reports
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Trials & Approvals Alzheimer's Disease
EMA Rejects Marketing Authorization Application of Aduhelm
2021-12-20
Innovation Alzheimer's Disease
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
Trials & Approvals Aduhelm
AC Immune’s Stock Climbs Following Mixed Phase 2 Trial Results for Alzheimer’s Disease Drug
2021-09-01
Trials & Approvals Alzheimer's Drug
Aftermath of Biogen’s Alzheimer’s Drug Approval Continues as Some Hospitals, Insurers Refuse Administration
2021-07-18
Trials & Approvals
Biogen’s Controversial Alzheimer’s Drug Wins Historic FDA Approval
2021-06-07
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top